Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bromocriptine for improving outcomes in peripartum cardiomyopathy is currently recruiting. Sponsor is Dennis M. McNamara, MD, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromocriptine (bromocriptine)

Snippet

Sponsor: Dennis M. McNamara, MD, MS | Conditions: Peripartum Cardiomyopathy, Postpartum | Phase 4 | Status: RECRUITING